Onyia Jude
SEC CIK 1894425 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| NBIX | NEUROCRINE BIOSCIENCES INC | CSO | 24.6K | — | $16.15M | 35 | 2022-11-29 | 2026-09-11 |
Most active insiders at NBIX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | GORMAN KEVIN CHARLES | Dir | — | $37.82M |
| 2 | Cooke Julie | CHRO | — | $5.77M |
| 3 | Gano Kyle | CEO, Dir | — | $4.87M |
| 4 | Lippoldt Darin | CLO | — | $4.20M |
| 5 | SHERWIN STEPHEN A | Dir | — | $4.13M |
| 6 | Delaet Ingrid | Chief Regulatory Off | — | $3.75M |
| 7 | Onyia Jude | CSO | — | $3.47M |
| 8 | RASTETTER WILLIAM H | Dir | — | $2.73M |
| 9 | POPS RICHARD F | Dir | — | $2.36M |
| 10 | LYONS GARY A | Dir | — | $2.29M |
Transactions 35
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-15 17:07 | 2026-09-11 | NBIX | NEUROCRINE BIOSCIENCES INC | Onyia Jude | CSO | A - Grant | $0.00 | +3,587 | 24.6K | +17% | $0 | |
| 2026-09-15 17:07 | 2026-09-11 | NBIX | NEUROCRINE BIOSCIENCES INC | Onyia Jude | CSO | F - Tax | $156.22 | -1,936 | 22.6K | -8% | -$302.4K | |
| 2026-08-05 17:35 | 2026-08-04 | NBIX | NEUROCRINE BIOSCIENCES INC | Onyia Jude | CSO | G - Gift | $0.00 | -2,409 | 21.0K | -10% | $0 | |
| 2026-06-09 17:34 | 2026-06-05 | NBIX | NEUROCRINE BIOSCIENCES INC | Onyia Jude | CSO | G - Gift | $0.00 | -2,441 | 23.4K | -9% | $0 | |
| DT | 2026-06-02 18:08 | 2026-06-01 | NBIX | NEUROCRINE BIOSCIENCES INC | Onyia Jude | CSO | M - OptEx | $84.74 | +11.0K | 36.8K | +43% | +$932.1K |
| DT | 2026-06-02 18:08 | 2026-06-01 | NBIX | NEUROCRINE BIOSCIENCES INC | Onyia Jude | CSO | S - Sale+OE | $160.25 | -11.0K | 25.8K | -30% | -$1.76M |
| DT | 2026-05-29 18:09 | 2026-05-27 | NBIX | NEUROCRINE BIOSCIENCES INC | Onyia Jude | CSO | M - OptEx | $84.74 | +11.0K | 36.8K | +43% | +$932.1K |
| DT | 2026-05-29 18:09 | 2026-05-27 | NBIX | NEUROCRINE BIOSCIENCES INC | Onyia Jude | CSO | S - Sale+OE | $155.53 | -11.0K | 25.8K | -30% | -$1.71M |
| 2026-02-23 | 2026-02-20 | NBIX | NEUROCRINE BIOSCIENCES INC | Onyia Jude | CSO | G - Gift | $0.00 | -3,110 | 25.7K | -11% | $0 | |
| DM | 2026-02-17 | 2026-02-12+ | NBIX | NEUROCRINE BIOSCIENCES INC | Onyia Jude | CSO | M - OptEx | $0.00 | +7,967 | 18.5K | +75% | $0 |
| DM | 2026-02-17 | 2026-02-12+ | NBIX | NEUROCRINE BIOSCIENCES INC | Onyia Jude | CSO | F - Tax | $124.02 | -15.1K | 18.3K | -45% | -$1.87M |
| D | 2026-02-17 | 2026-02-13 | NBIX | NEUROCRINE BIOSCIENCES INC | Onyia Jude | CSO | A - Grant | $0.00 | +19.9K | 39.5K | +102% | $0 |
| D | 2026-02-03 | 2026-01-31 | NBIX | NEUROCRINE BIOSCIENCES INC | Onyia Jude | CSO | F - Tax | $136.06 | -142 | 16.0K | -0.9% | -$19.3K |
| D | 2026-02-03 | 2026-01-31 | NBIX | NEUROCRINE BIOSCIENCES INC | Onyia Jude | CSO | M - OptEx | $0.00 | +238 | 16.1K | +1% | $0 |
| D | 2025-12-02 | 2025-11-29 | NBIX | NEUROCRINE BIOSCIENCES INC | Onyia Jude | CSO | F - Tax | $152.16 | -2,248 | 15.9K | -12% | -$342.1K |
| D | 2025-12-02 | 2025-11-29 | NBIX | NEUROCRINE BIOSCIENCES INC | Onyia Jude | CSO | M - OptEx | $0.00 | +4,426 | 18.1K | +32% | $0 |
| 2025-09-04 | 2025-09-03 | NBIX | NEUROCRINE BIOSCIENCES INC | Onyia Jude | CSO | G - Gift | $0.00 | -1,470 | 13.7K | -10% | $0 | |
| 2025-08-07 | 2025-08-05 | NBIX | NEUROCRINE BIOSCIENCES INC | Onyia Jude | CSO | G - Gift | $0.00 | -3,116 | 15.2K | -17% | $0 | |
| D | 2025-07-11 | 2025-07-09 | NBIX | NEUROCRINE BIOSCIENCES INC | Onyia Jude | CSO | S - Sale+OE | $130.46 | -59.8K | 18.3K | -77% | -$7.80M |
| D | 2025-07-11 | 2025-07-09 | NBIX | NEUROCRINE BIOSCIENCES INC | Onyia Jude | CSO | M - OptEx | $84.74 | +59.8K | 78.1K | +327% | +$5.07M |
| D | 2025-07-07 | 2025-07-02 | NBIX | NEUROCRINE BIOSCIENCES INC | Onyia Jude | CSO | M - OptEx | $84.74 | +20.4K | 38.7K | +111% | +$1.73M |
| D | 2025-07-07 | 2025-07-02 | NBIX | NEUROCRINE BIOSCIENCES INC | Onyia Jude | CSO | S - Sale+OE | $130.13 | -20.4K | 18.3K | -53% | -$2.65M |
| DM | 2025-02-14 | 2025-02-13 | NBIX | NEUROCRINE BIOSCIENCES INC | Onyia Jude | CSO | M - OptEx | $0.00 | +5,407 | 19.5K | +38% | $0 |
| DM | 2025-02-14 | 2025-02-13 | NBIX | NEUROCRINE BIOSCIENCES INC | Onyia Jude | CSO | S - Sale+OE | $116.79 | -2,879 | 16.8K | -15% | -$336.2K |
| D | 2025-02-04 | 2025-01-31 | NBIX | NEUROCRINE BIOSCIENCES INC | Onyia Jude | CSO | S - Sale+OE | $152.97 | -126 | 15.6K | -0.8% | -$19.3K |
| D | 2025-02-04 | 2025-01-31 | NBIX | NEUROCRINE BIOSCIENCES INC | Onyia Jude | CSO | M - OptEx | $0.00 | +238 | 15.7K | +2% | $0 |
| D | 2024-12-03 | 2024-11-29 | NBIX | NEUROCRINE BIOSCIENCES INC | Onyia Jude | CSO | S - Sale+OE | $126.29 | -2,331 | 15.4K | -13% | -$294.4K |
| D | 2024-12-03 | 2024-11-29 | NBIX | NEUROCRINE BIOSCIENCES INC | Onyia Jude | CSO | M - OptEx | $0.00 | +4,426 | 17.8K | +33% | $0 |
| D | 2024-02-15 | 2024-02-13 | NBIX | NEUROCRINE BIOSCIENCES INC | Onyia Jude | CSO | S - Sale | $132.94 | -1,432 | 13.1K | -10% | -$190.4K |
| 2024-02-02 | 2024-01-31 | NBIX | NEUROCRINE BIOSCIENCES INC | Onyia Jude | CSO | S - Sale | $141.94 | -126 | 11.8K | -1% | -$17.9K | |
| 2023-12-01 | 2023-11-29 | NBIX | NEUROCRINE BIOSCIENCES INC | Onyia Jude | CSO | S - Sale | $113.57 | -2,331 | 11.7K | -17% | -$264.7K | |
| 2023-08-23 | 2023-08-21 | NBIX | NEUROCRINE BIOSCIENCES INC | Onyia Jude | CSO | S - Sale | $107.37 | -3,198 | 9,638 | -25% | -$343.4K | |
| 2023-02-08 | 2023-02-07 | NBIX | NEUROCRINE BIOSCIENCES INC | Onyia Jude | CSO | S - Sale | $102.30 | -4,508 | 6,525 | -41% | -$461.2K | |
| 2023-02-02 | 2023-01-31 | NBIX | NEUROCRINE BIOSCIENCES INC | Onyia Jude | CSO | S - Sale | $108.48 | -126 | 2,477 | -5% | -$13.7K | |
| 2022-12-01 | 2022-11-29 | NBIX | NEUROCRINE BIOSCIENCES INC | Onyia Jude | CSO | S - Sale | $121.90 | -2,331 | 2,366 | -50% | -$284.1K |
Purchase Sale Sale after option exercise All abbreviations